Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

Share Price is delayed by 15 minutes
Get Live Data
116.40    0.80 (0.69%)
Bid:
116.20
Ask:
116.40
Spread: 0.20 (0.172%)
Market Cap: £207.63m
TTG Live PriceLast checked at - London Stock Exchange

Intraday Tt Electronics Share Chart

Director Declaration

12 Jun 2019 09:40

RNS Number : 9488B
TT Electronics PLC
12 June 2019
 

 

 

12 June 2019

 

TT Electronics plc

 

Board Change

 

TT Electronics plc, a global provider of engineered electronics for performance critical applications, today announces that Anne Thorburn will join the Board as a Non-executive Director and member of the Audit and Nominations Committees with effect from 1 July 2019.

 

Anne is a Non-executive Director and Chairman of the Audit Committee at Diploma and a Non-executive Director of BTG. Anne was Chief Financial Officer of Exova from 2009 to 2015 and previously Group Financial Director of British Polythene Industries. Anne is a member of the Institute of Chartered Accountants in Scotland.

 

Neil Carson, Chairman, said "I am delighted to welcome Anne to the Board of TT Electronics. She has many years of experience at Board level in listed international businesses, including those operating in life sciences and medical markets, where TT has a growing presence. Anne has particular expertise in financial management, risk, audit and M&A and I am sure she will make a valuable contribution to the ongoing transformation of TT."

 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to this appointment.

 

 

For further information please contact:

 

 

 

MHP Communications

Tel: +44 (0)20 3128 8156

Tim Rowntree / Guy Featherstone

 

 

 

   

About TT Electronics

TT Electronics is a global provider of engineered electronics for performance critical applications.

The company operates in industries where there are structural growth drivers, working with market-leading customers in industrial, medical, aerospace and defence, and transportation sectors. Products designed and manufactured include sensors, power management devices and connectivity solutions. TT has design and manufacturing facilities in the UK, US, Sweden and Asia.

The company has three divisions. The Sensors and Specialist Components division works with customers to develop standard and customised solutions including sensors and power management devices. Our solutions improve the precision, speed and reliability of critical aspects of our customers' applications. The Power and Connectivity division designs and manufactures power application products and connectivity devices which enable the capture and wireless transfer of data. We collaborate with our customers to develop innovative solutions to optimise their electronic systems. The Global Manufacturing Solutions division provides manufacturing services and engineering solutions for our product divisions and to customers that often require a lower volume and higher mix of different products. We manufacture complex integrated product assemblies for our customers and provide engineering services including designing testing solutions and value-engineering.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNGGURWQUPBURP
Date   Source Headline
28th Apr 20226:05 pmRNSDirector/PDMR Shareholding
27th Apr 20225:20 pmRNSDirector/PDMR Shareholding
27th Apr 202211:22 amRNSHolding(s) in Company
6th Apr 20224:15 pmRNSAnnual Financial Report
17th Mar 20227:00 amRNSDirector/PDMR Shareholding
16th Mar 20224:16 pmRNSDirector/PDMR Shareholding
15th Mar 202211:29 amRNSDirector Declaration
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
14th Mar 20223:00 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSFull Year Results
1st Mar 20223:35 pmRNSTotal Voting Rights
2nd Feb 20224:30 pmRNSHolding(s) in Company
1st Feb 20223:05 pmRNSTotal Voting Rights
10th Jan 20227:00 amRNSAcquisition of Ferranti Power & Control business
4th Jan 20222:20 pmRNSTotal Voting Rights
22nd Dec 202110:07 amRNSHolding(s) in Company
15th Dec 20214:00 pmRNSHolding(s) in Company
1st Dec 20213:06 pmRNSTotal Voting Rights
23rd Nov 20217:00 amRNSTrading Update
1st Nov 20215:05 pmRNSBlock Listing Six Monthly Return
1st Nov 20214:56 pmRNSDirector/PDMR Shareholding
30th Sep 20219:40 amRNSDirector/PDMR Shareholding
1st Sep 20211:30 pmRNSTotal Voting Rights
5th Aug 20217:00 amRNSHalf-year Results
2nd Aug 20213:38 pmRNSTotal Voting Rights
2nd Jul 20215:10 pmRNSTotal Voting Rights
16th Jun 20211:32 pmRNSUpdate on 2021 LTIP Award Targets
14th Jun 202110:16 amRNSHolding(s) in Company
1st Jun 20218:11 amRNSTotal Voting Rights
13th May 20211:19 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Update
12th May 20214:39 pmRNSDirector/PDMR Shareholding
4th May 20213:00 pmRNSBlock listing Interim Review
4th May 202110:42 amRNSTotal Voting Rights
1st Apr 20214:22 pmRNSTotal Voting Rights
1st Apr 202111:23 amRNSAnnual Report and AGM Arrangements
29th Mar 20218:05 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSVirolens® registration received in Great Britain
25th Mar 202112:11 pmRNSUpdate on Virolens
19th Mar 202112:11 pmRNSDirector/PDMR Shareholding
18th Mar 20213:18 pmRNSHolding(s) in Company
16th Mar 20213:50 pmRNSDirector/PDMR Shareholding
16th Mar 20213:49 pmRNSDirector/PDMR Shareholding
10th Mar 202112:40 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSFull Year Results
1st Mar 202112:30 pmRNSTotal Voting Rights
8th Feb 20216:20 pmRNSHolding(s) in Company
1st Feb 202111:36 amRNSTotal Voting Rights
20th Jan 20214:55 pmRNSHolding(s) in Company
19th Jan 20213:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.